[{"AccountsPayableCurrent_0_Q3_USD":1736000.0,"PreferredStockConvertibleConversionRatio_0_Q3_pure":1.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":1306000.0,"PaymentsOfStockIssuanceCosts_3_Q3_USD":1416000.0,"OtherAssetsCurrent_0_Q3_USD":55000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":735000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.0351,"OperatingLeaseRightOfUseAsset_0_Q3_USD":1096000.0,"OperatingLeasePayments_3_Q3_USD":367000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":513000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":607000.0,"OperatingLeaseLiability_0_Q3_USD":1120000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":1609000.0,"OperatingLeaseExpense_3_Q3_USD":4000.0,"OperatingLeaseCost_1_Q3_USD":154000.0,"OperatingIncomeLoss_3_Q3_USD":-23623000.0,"OperatingIncomeLoss_1_Q3_USD":-8895000.0,"OperatingCostsAndExpenses_3_Q3_USD":23623000.0,"OperatingCostsAndExpenses_1_Q3_USD":8895000.0,"NonoperatingIncomeExpense_3_Q3_USD":6000.0,"NonoperatingIncomeExpense_1_Q3_USD":57000.0,"NetIncomeLoss_3_Q3_USD":-23617000.0,"NetIncomeLoss_1_Q3_USD":-8838000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-20324000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-1306000.0,"OperatingLeaseCost_3_Q3_USD":370000.0,"PrepaidInsurance_0_Q3_USD":80000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":305000.0,"ProfitLoss_3_Q3_USD":-23617000.0,"VariableLeaseCost_3_Q3_USD":233000.0,"VariableLeaseCost_1_Q3_USD":90000.0,"UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0_Q3_USD":0.0,"TemporaryEquityParOrStatedValuePerShare_0_Q3_USD":0.0,"TemporaryEquityAccretionToRedemptionValueAdjustment_3_Q3_USD":9627000.0,"TemporaryEquityAccretionToRedemptionValueAdjustment_1_Q3_USD":3668000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":20000.0,"StockholdersEquity_0_Q3_USD":-131015000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":3.97,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3_Q3_USD":10000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3_Q3_pure":0.0106,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q3_pure":0.01,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3_Q3_pure":0.7421,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q3_pure":0.7336,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_Q3_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q3_pure":0.0,"ShareBasedCompensation_3_Q3_USD":1010000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":516000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-140503000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q3_USD":125000.0,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q3_USD":20000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":17182000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":6365000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":4442000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":6975000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":86117000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":441448.0,"LiabilitiesCurrent_0_Q3_USD":5831000.0,"Liabilities_0_Q3_USD":6415000.0,"Depreciation_1_Q3_USD":200000.0,"DeferredOfferingCosts_0_Q3_USD":1600000.0,"DeferredCosts_0_Q3_USD":1583000.0,"CommonStockValue_0_Q3_USD":null,"CommonStockSharesOutstanding_0_Q3_shares":442717.0,"CommonStockSharesIssued_0_Q3_shares":442717.0,"CommonStockSharesAuthorized_0_Q3_shares":470183383.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":64487000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":81974000.0,"Depreciation_3_Q3_USD":601000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":81974000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":159000.0,"AssetsCurrent_0_Q3_USD":83458000.0,"Assets_0_Q3_USD":90704000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":25728196.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":25728196.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":1010000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":554000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":554000.0,"AdditionalPaidInCapital_0_Q3_USD":9488000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":2533000.0,"AccruedEmployeeBenefitsCurrent_0_Q3_USD":1569000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":81829000.0,"DividendsCommonStockStock_3_Q3_USD":0.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-28.33,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-77.93,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":35000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":153000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":377000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":625000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":1155000.0,"LeaseCost_3_Q3_USD":614000.0,"LeaseCost_1_Q3_USD":244000.0,"InterestIncomeExpenseAfterProvisionForLoanLoss_3_Q3_USD":8000.0,"InterestIncomeExpenseAfterProvisionForLoanLoss_1_Q3_USD":5000.0,"IncreaseDecreaseInPrepaidExpensesOther_3_Q3_USD":566000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":1357000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":891000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":6441000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":2530000.0,"GainLossOnSaleOfPropertyPlantEquipment_3_Q3_USD":3000.0,"FinanceLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.0794,"FinanceLeaseRightOfUseAssetAmortization_3_Q3_USD":11000.0,"FinanceLeasePrincipalPayments_3_Q3_USD":15000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_3_Q3_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_3_Q3_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_3_Q3_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_3_Q3_USD":0.0,"FairValueAdjustmentOfWarrants_3_Q3_USD":-1000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q3_USD":7900000.0,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":0.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":90704000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":426604.0,"Ticker":"AURA","CIK":"1501796","name":"AURA BIOSCIENCES, INC.","OfficialName":"Aura Biosciences Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"518605939.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211124"}]